8-K ·Filed Mar 18, 2026
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight • Neutral
Traders should await disclosure of the full filing to assess potential dilution, use of proceeds, and strategic implications of the material agreement. Given ARTL's small market cap ($3M), even modest dilution or deal commitments could be significant.
Final — all horizons settled through T+60d
ARTL ▼ -81.84% at T+60d
NEUTRAL call -81.84% · α vs SPY -96.19% · entry $7.16 → $1.30
T+1d
+11.31%
call +11.31% · α +13.05%
$7.97
settled 7mo ago
T+5d
-55.45%
call -55.45% · α -53.24%
$3.19
settled 7mo ago
T+20d
-37.99%
call -37.99% · α -45.61%
$4.44
settled 6mo ago
T+60d
-81.84%
call -81.84% · α -96.19%
$1.30
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K reports entry into a material agreement and unregistered sales of securities, but without access to the filing details, the nature, terms, and financial impact of these events cannot be determined.
Key Facts
- Artelo Biosciences, Inc. (ARTL) filed an 8-K with Items 1.01 (Entry into Material Agreement) and 3.02 (Unregistered Sales of Equity Securities) reported.
- Item 9.01 indicates financial statements and exhibits were filed, but content is unavailable.
- No details on the agreement counterparties, terms, or purpose of the unregistered securities sale are accessible.
Financial Impact
Not specified
dilutiondebtrevenuecash_flow
Risk Factors
- Potential for significant shareholder dilution if the unregistered securities sale was a large private placement at a discount.
- Material agreement could involve unfavorable terms or contingent liabilities not yet disclosed.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
Report based on filing metadata.
23 reports for ARTL
90% Hit rate @ T+60 Went positive at some point 11 of 12 best @ T+5▲ +94.93%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $3.11 | awaiting T+60 | — | $2.20 (+29.26%) |
Sep 16, 2026 5w ago | Press Release | $3.75 | awaiting T+60 | — | $2.20 (−41.33%) |
Aug 13, 2026 10w ago | Press Release | $6.83 | awaiting T+60 | — | $2.20 (−67.79%) |
Jul 16, 2026 14w ago | DEFA14A | $1.14 $0.3622 | ▼ −68.23% | ▼ −71.94% | $2.20 (+92.98%) |
Jul 16, 2026 14w ago | Press Release | $1.14 $0.3622 | ▼ −68.23% | ▼ −71.94% | $2.20 (+92.98%) |
Jul 13, 2026 15w ago | Press Release | $1.05 $0.3844 | ▼ −63.39% | ▼ −67.38% | $2.20 (+109.52%) |
Jul 2, 2026 16w ago | DEFA14A | $1.11 $0.4522 | ▲ +59.26% | ▲ +60.98% | $2.20 (−98.20%) |
May 27, 2026 21w ago | 8-K | $1.46 $0.6920 | ▲ +52.60% | ▲ +54.34% | $2.20 (−50.68%) |
May 18, 2026 23w ago | 424B5 | $1.36 $0.7587 | ▼ −44.21% | ▼ −50.50% | $2.20 (+61.76%) |
May 15, 2026 23w ago | 8-K | $1.46 $0.7330 | ▼ −49.79% | ▼ −54.65% | $2.20 (+50.68%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Wed (17h 25m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers